FreeObituary Ben Seon, immunologist whose work led to development of lymphoma drug Polivy, dies at 89 January 16, 2026Vol.52 No.02By Roswell Park Comprehensive Cancer Center
A planned randomized trial will ask an intriguing question: Do COVID vaccines potentiate checkpoint inhibitors? January 09, 2026Vol.52 No.1By Sara Willa Ernst and Jacquelyn Cobb
Trials & Tribulations How a Montefiore Einstein screening program is changing the history of lung cancer in the Bronx January 09, 2026Vol.52 No.1By Brendon M. Stiles
FreeObituary MSK’s AML researcher Bayard “Barney” Clarkson, former president of ASCO and AACR, dies at 99 January 09, 2026Vol.52 No.1By Paul Goldberg
FreeObituary Paul Engstrom, Fox Chase pioneer of cancer prevention, dies at 89 January 09, 2026Vol.52 No.1By Robert G. Uzzo
FreeObituary Patient advocate David Mitchell, 75, dies of multiple myeloma January 09, 2026Vol.52 No.1By Ellen V. Sigal
Sponsored Composite intelligence: How AI-driven biomarkers are setting the bar in immuno-oncology January 09, 2026Vol.52 No.1By Ofer Sharon, Michal Harel and Yehonatan Elon
PodcastThe Directors The Directors: Joann Sweasy and Robert Winn reflect on lessons learned during a tough yearFormer and current AACI presidents agree: strategic communication is key to safeguarding the future of cancer research December 19, 2025Vol.51 No.46By Claire Marie Porter and Paul Goldberg
Guest Editorial With streamlined, “sitevisitless” CCSG review in place, cancer centers remained stable in 2025 December 19, 2025Vol.51 No.46By Richard J. Jones
Should I have a drink tonight?In anticipation of the first holiday season since the surgeon general’s report on alcohol and cancer, we ask experts to weigh in December 19, 2025Vol.51 No.46By Jacquelyn Cobb
